| __timestamp | Corcept Therapeutics Incorporated | Gilead Sciences, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 882000 | 3788000000 |
| Thursday, January 1, 2015 | 1361000 | 4006000000 |
| Friday, January 1, 2016 | 2058000 | 4261000000 |
| Sunday, January 1, 2017 | 3554000 | 4371000000 |
| Monday, January 1, 2018 | 5215000 | 4853000000 |
| Tuesday, January 1, 2019 | 5504000 | 4675000000 |
| Wednesday, January 1, 2020 | 5582000 | 4572000000 |
| Friday, January 1, 2021 | 5281000 | 6601000000 |
| Saturday, January 1, 2022 | 5385000 | 5657000000 |
| Sunday, January 1, 2023 | 6481000 | 6498000000 |
| Monday, January 1, 2024 | 28675800000 |
Unleashing insights
In the ever-evolving landscape of biotechnology, Gilead Sciences, Inc. and Corcept Therapeutics Incorporated stand as intriguing case studies in cost management. From 2014 to 2023, Gilead's cost of revenue has consistently dwarfed that of Corcept, averaging around $4.9 billion annually, compared to Corcept's $4.1 million. This stark contrast highlights the scale at which Gilead operates, with its cost of revenue peaking at $6.6 billion in 2021, a year marked by significant global health challenges.
Corcept, on the other hand, has shown a steady increase in its cost of revenue, growing by over 600% from 2014 to 2023. This growth reflects its expanding operations and market presence. As we delve into these figures, it becomes evident that while Gilead's financial muscle is formidable, Corcept's growth trajectory is a testament to its strategic advancements in the biotech sector.
Comparing Cost of Revenue Efficiency: Gilead Sciences, Inc. vs Vericel Corporation
Cost of Revenue Trends: Gilead Sciences, Inc. vs Amphastar Pharmaceuticals, Inc.
Gilead Sciences, Inc. vs Dyne Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Gilead Sciences, Inc. and Evotec SE's Expenses
Comparing Cost of Revenue Efficiency: Zoetis Inc. vs Corcept Therapeutics Incorporated
Cost of Revenue: Key Insights for BeiGene, Ltd. and Corcept Therapeutics Incorporated
Cost Insights: Breaking Down Jazz Pharmaceuticals plc and Corcept Therapeutics Incorporated's Expenses
Cost Insights: Breaking Down Pharming Group N.V. and Corcept Therapeutics Incorporated's Expenses
Cost of Revenue: Key Insights for Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated vs HUTCHMED (China) Limited: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Corcept Therapeutics Incorporated and Wave Life Sciences Ltd.
Cost Insights: Breaking Down Corcept Therapeutics Incorporated and Celldex Therapeutics, Inc.'s Expenses